9.35000 EUR
0.4
4.47%
Last update Dec 12, 8:35 PM CET
Market closed
Day range
9.15000
9.35000
Previous close
8.95000
Open
9.15000
Access this stock data via API
Subscribe
Innovent Biologics Inc.
9.35
0.40
4.47%

Financials

Income statement

Fundamentals currency is CNY
Fiscal date 2024 2023 2022 2021
Total reported revenue 1.1B 750.2M 545.5M 4.3B
Cost of revenue 182.6M 137.4M 111.5M 505.3M
Gross profit 956.4M 612.8M 434.0M 3.8B
Operating expense
Research & development 324.1M 269.3M 343.7M 2.3B
Selling general and admin 614.7M 465.5M 410.2M 3.4B
Other operating expenses
Operating income 31.2M -109.9M -309.1M -1.9B
Non operating interest income
Income 51.2M 54.7M 22.7M 151.8M
Expense 8.2M 11.9M 12.2M 62.5M
Other income expense
Pretax income -9.5M -138.3M -259.8M -2.6B
Tax provision 1.9M -14.1M 1.1M 87.0M
Net income -11.4M -124.3M -260.9M -2.7B
Basic EPS -0.1 -0.7 -1.5 -1.9
Diluted EPS -0.1 -0.7 -1.5 -1.9
Basic average shares 196.7M 188.5M 178.4M 12.0B
Diluted average shares 196.7M 188.5M 178.4M 12.0B
EBITDA 30.6M -83.5M -210.1M -2.5B
Net income from continuing op. -9.5M -138.3M -259.8M -2.6B
Minority interests
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 3 hours 50 minutes

04:09
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).